Skip to main content
SpringerLink
Log in

Osteonecrosis in Sickle-Cell Disease

  • Chapter
  • First Online:
Osteonecrosis

Abstract

Sickle-cell disease (SCD), an autosomal recessive disorder, is also called sickle-cell anemia (SCA) due to the hemolytic anemia characterized by abnormally shaped (sickled) red blood cells (RBCs), which are removed from the circulation and destroyed at increased rates, leading to anemia. Of greater clinical importance, the sickled RBCs cause vascular occlusion, which leads to tissue ischemia and infarction. The patients who are homozygous for the sickle-cell gene (hemoglobin SS) have a high risk of bone osteonecrosis [1–3] due to microvascular occlusion in relation to the disturbance in the erythrocyte architecture and the polymerization of hemoglobin S (in a deoxygenated state) producing cells that are crescent- or sickle-shaped with decreased deformability; the decreased deformability results in greater risk for clotting in small vessels. The incidence of osteonecrosis is also high in patients with hemoglobin SC (compound heterozygotes for Hb S- and Hb C-producing alleles: SC) and in the various types of sickle-beta-thalassemia (SThal) population. So, patients with sickle-cell disease often present with orthopedic disease manifestations requiring surgical intervention, with the most common indications being osteonecrosis and osteomyelitis. This article based on the experience of the authors treating more than 2,000 patients with SCD reviews the incidence of multifocal osteonecrosis in this disease, the distribution of the joints concerned by multifocal osteonecrosis, and the clinical consequences in the long term (average 15 years of follow-up) of multifocal osteonecrosis in these patients with sickle-cell disease and includes an approach to the medical and surgical management of patients with orthopedic complications related to sickle-cell disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83–9.

    Article  CAS  PubMed  Google Scholar 

  2. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459–74.

    CAS  PubMed  Google Scholar 

  3. Mukisi-Mukaza M, Elbaz A, Samuel Leborgne Y, et al. Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease. Orthopedics. 2000;23:357–63.

    CAS  PubMed  Google Scholar 

  4. Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med. 1910;6:517–21.

    Article  Google Scholar 

  5. Steinberg B. Sickle cell anemia. Arch Pathol. 1930;9:876–97.

    Google Scholar 

  6. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle-cell anemia: a molecular disease. Science. 1949;110:543–9.

    Article  CAS  PubMed  Google Scholar 

  7. Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature. 1957;180:326–8.

    Article  CAS  PubMed  Google Scholar 

  8. Bowman JE, Murray RFJ. Genetic variation in peoples of African origin. Baltimore: Johns Hopkins University Press; 1990. p. 196–201.

    Google Scholar 

  9. Aluoch JR. Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. N Engl J Med. 1997;317:781–7.

    Google Scholar 

  10. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19:1–11.

    Article  PubMed  Google Scholar 

  11. Steinberg MH. Modulation of fetal hemoglobin in sickle cell anemia. Hemoglobin. 2001;25:195–211.

    Article  CAS  PubMed  Google Scholar 

  12. Steinberg MH, Nagel RL, Higgs D, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. New York: Cambridge University Press; 2001.

    Google Scholar 

  13. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med. 1980;302:992–5.

    Article  CAS  PubMed  Google Scholar 

  14. Hebbel RP, Vercelotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med. 1997;129:288–93.

    Article  CAS  PubMed  Google Scholar 

  15. Manodori AB, Matsui NM, Chen JY, Embury SH. Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation. Blood. 1998;92:3445–54.

    CAS  PubMed  Google Scholar 

  16. Michaels LA, Ohene-Frempong K, Zhao H, Douglas SD. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood. 1998;92:3148–51.

    CAS  PubMed  Google Scholar 

  17. Hawker H, Neilson H, Hayes RJ, Sergeant GR. Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. Br J Haematol. 1982;50:29–34.

    Article  CAS  PubMed  Google Scholar 

  18. Wethers DL. Sickle cell disease in childhood. I. Laboratory diagnosis, pathophysiology, and health maintenance. Am Fam Phys. 2000;62:1013–20.

    CAS  Google Scholar 

  19. Hernigou P, Daltro G, Sobrinho UB, Sberge F. Manifestações osteoarticulares na anemia falciforme. Gaz Méd Bahia. 2010;80(3):74–9.

    Google Scholar 

  20. Mukisi Mukaza M, Manicom O, Fillipini P, Hernigou P. Elbow osteonecrosis in sickle cells anemia: a study of six cases. Orthop Traumatol Surg Res. 2009;95(1):82–4.

    Article  CAS  PubMed  Google Scholar 

  21. Flouzat-Lachaniete CH, Roussignol X, Poignard A, Mukasa MM, Manicom O, Hernigou P. Multifocal joint osteonecrosis in sickle cell disease. Op Orthop J. 2009;3:32–5.

    Article  Google Scholar 

  22. Poignard A, Flouzat-Lachaniette CH, Amzallag J, Galacteros F, Hernigou P. The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease. J Bone Joint Surg Am. 2012;94(2):156–62.

    Article  PubMed  Google Scholar 

  23. Hernigou P, Galacteros F, Bachir D, Goutallier D. Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am. 1991;73:81–92.

    CAS  PubMed  Google Scholar 

  24. Hernigou P, Daltro G, Flouzat-Lachaniette CH, Roussignol X, Poignard A. Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis. Clin Orthop Relat Res. 2010;468(6):1676–81.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Chung SM, Ralston EL. Necrosis of the femoral head associated with sickle-cell anemia and its genetic variants. A review of the literature and study of thirteen cases. J Bone Joint Surg Am. 1969;51:33–58.

    CAS  PubMed  Google Scholar 

  26. Daltro G, de Alencar Daniel F, Sobrinho UB, Guedes A, Fortuna VA. Osteonecrose da cabeça femoral na anemia falciforme. Gaz Méd Bahia. 2010;80(3):29–32.

    Google Scholar 

  27. Diggs LW. Bone and joint lesions in sickle-cell disease. Clin Orthop Relat Res. 1967;52:119–43.

    Article  CAS  PubMed  Google Scholar 

  28. Hernigou P, Bachir D, Galacteros F. Avascular necrosis of the femoral head in sickle-cell disease. Treatment of collapse by the injection of acrylic cement. J Bone Jt Surg Br. 1993;75:875–80.

    CAS  Google Scholar 

  29. Hernigou P, Zilber S, Filippini P, Mathieu G, Poignard A, Galacteros F. THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res. 2008;466(2):300–8.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Vichinsky EP, Neumayr LD, Haberkem C, et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol. 1999;62:129–38.

    Article  CAS  PubMed  Google Scholar 

  31. Serjeant GR. Natural history and determinants of clinical severity of sickle cell disease. Curr Opin Hematol. 1995;2:103–8.

    Article  CAS  PubMed  Google Scholar 

  32. Castro O. Management of sickle cell disease: recent advances and controversies. Br J Haematol. 1999;107:2–11.

    Article  CAS  PubMed  Google Scholar 

  33. Garden MS, Grant RE, Jebraili S. Perioperative complications in patients with sickle cell disease. An orthopedic perspective. Am J Orthop. 1996;25:353–6.

    CAS  PubMed  Google Scholar 

  34. Aldrich TK, Dhuper SK, Patwa NS, et al. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol. 1996;80:531–9.

    CAS  PubMed  Google Scholar 

  35. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855–15865.

    Article  CAS  PubMed  Google Scholar 

  36. Gelfand MJ, Daya SA, Rucknagel DL, Kallinyak KA, Paltiel HJ. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med. 1993;34:614–8.

    CAS  PubMed  Google Scholar 

  37. Rodgers GP. Overview of pathophysiology and rationale for treatment of sickle cell anemia. Semin Hematol. 1997;34:2–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, University Paris East, 51 avenue du Maréchal de Lattre de Tassigny, Créteil, 94010 cedex, France

    Philippe Hernigou

  2. Department of Orthopaedic Surgery, Hospital Edgar Santos, University Federal of Bahia, Salvador, Brazil

    Gildasio Daltro

Authors
  1. Philippe Hernigou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gildasio Daltro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philippe Hernigou .

Editor information

Editors and Affiliations

  1. Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Kyonggi-do, Korea, Republic of (South Korea)

    Kyung-Hoi Koo

  2. Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, Maryland, USA

    Michael A. Mont

  3. Department of Orthopaedic Surgery, Department of Orthopaedic Surgery, Center for Metabolism and Obesity Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Lynne C. Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hernigou, P., Daltro, G. (2014). Osteonecrosis in Sickle-Cell Disease. In: Koo, KH., Mont, M., Jones, L. (eds) Osteonecrosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35767-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35767-1_16

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35766-4

  • Online ISBN: 978-3-642-35767-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation